Page last updated: 2024-12-05

2-methylanthraquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

2-Methylanthraquinone is an organic compound with the formula C15H10O2. It is a bright yellow solid that is sparingly soluble in water. It is synthesized by the Friedel-Crafts acylation of anthracene with acetyl chloride in the presence of aluminum chloride. 2-Methylanthraquinone has a variety of applications, including as a dye intermediate, a pharmaceutical ingredient, and a reagent in organic synthesis. It is also studied for its potential biological activity. 2-Methylanthraquinone is a potent inhibitor of the enzyme tyrosinase, which is involved in the production of melanin. This property has led to research into its potential use as a skin-whitening agent. 2-Methylanthraquinone has also been shown to exhibit anti-inflammatory and antioxidant activities.'

2-methylanthraquinone: form Morinda officinalis How. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

2-methylanthraquinone : An anthraquinone that is 9,10-anthraquinone in which the hydrogen at position 2 is substituted by a methyl group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

FloraRankFlora DefinitionFamilyFamily Definition
MorindagenusA plant genus of the family RUBIACEAE. Members contain iridoid glycosides and ANTHRAQUINONES.[MeSH]RubiaceaeThe Madder plant family of the order Gentianales (formerly Rubiales), subclass Asteridae, class Magnoliopsida includes important medicinal plants that provide QUININE; IPECAC; and COFFEE. They have opposite leaves and interpetiolar stipules.[MeSH]
Morinda officinalisspecies[no description available]RubiaceaeThe Madder plant family of the order Gentianales (formerly Rubiales), subclass Asteridae, class Magnoliopsida includes important medicinal plants that provide QUININE; IPECAC; and COFFEE. They have opposite leaves and interpetiolar stipules.[MeSH]

Cross-References

ID SourceID
PubMed CID6773
CHEMBL ID21745
CHEBI ID9427
SCHEMBL ID36822
MeSH IDM0199759

Synonyms (57)

Synonym
2-methyl-anthracene-9,10-dione
EU-0067001
beta-methylanthraquinone
2-methyl-9,10-anthraquinone
2-methyl-9,10-anthracenedione
CHEBI:9427 ,
2-methylanthracene-9,10-dione
9,10-anthracenedione, 2-methyl-
inchi=1/c15h10o2/c1-9-6-7-12-13(8-9)15(17)11-5-3-2-4-10(11)14(12)16/h2-8h,1h
2-methylanthra-9,10-quinone
anthraquinone, 2-methyl-
techtoquinone
nsc607
84-54-8
tectoquinone
9, 2-methyl-
2-methylanthraquinone
tectochinon
.beta.-methylanthraquinone
nsc-607
2-methylanthraquinone, technical, >=95% (hplc)
ccris 5484
ai3-15182
nsc 607
einecs 201-539-6
CHEMBL21745 ,
2-methyl-anthraquinone
AKOS000400281
M0156
bdbm50005894
A840843
2-methyl anthraquinone
dtxcid3021439
NCGC00255621-01
tox21_302044
cas-84-54-8
dtxsid5041439 ,
unii-q9p233hwaj
q9p233hwaj ,
AM62660
FT-0613005
STL380671
AE-641/00352041
2-methylanthraquinone [mi]
methylanthraquinone, 2-
SCHEMBL36822
W-104113
2-methyl-9,10-dihydroanthracene-9,10-dione
mfcd00001235
2-maq
Q22984229
2-methyl anthraquinone;tectoquinone
BCP33087
ethyl 2-cyano-2-(4-fluoro-2-nitrophenyl)acetate
D85134
HY-N1739
CS-0017415
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
anthraquinone
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (23)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
LuciferasePhotinus pyralis (common eastern firefly)Potency14.11610.007215.758889.3584AID1224835
RAR-related orphan receptor gammaMus musculus (house mouse)Potency6.60260.006038.004119,952.5996AID1159521; AID1159523
GLI family zinc finger 3Homo sapiens (human)Potency10.82650.000714.592883.7951AID1259392
AR proteinHomo sapiens (human)Potency19.95760.000221.22318,912.5098AID1259243; AID1259247; AID1259381; AID743040; AID743042; AID743054
caspase 7, apoptosis-related cysteine proteaseHomo sapiens (human)Potency1.92530.013326.981070.7614AID1346978
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency48.36030.000657.913322,387.1992AID1259377
nuclear receptor subfamily 1, group I, member 3Homo sapiens (human)Potency25.53950.001022.650876.6163AID1224838; AID1224839; AID1224893
glucocorticoid receptor [Homo sapiens]Homo sapiens (human)Potency54.74610.000214.376460.0339AID720692
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency6.26770.003041.611522,387.1992AID1159552; AID1159553; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency23.65470.001530.607315,848.9004AID1224841; AID1224842; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency15.29290.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency13.68580.000229.305416,493.5996AID1259244; AID1259248; AID1259383; AID743069; AID743078; AID743079; AID743080; AID743091
caspase-3Homo sapiens (human)Potency1.92530.013326.981070.7614AID1346978
aryl hydrocarbon receptorHomo sapiens (human)Potency41.96810.000723.06741,258.9301AID743085; AID743122
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_aHomo sapiens (human)Potency3.84140.001723.839378.1014AID743083
thyroid hormone receptor beta isoform 2Rattus norvegicus (Norway rat)Potency2.24330.000323.4451159.6830AID743065; AID743067
histone deacetylase 9 isoform 3Homo sapiens (human)Potency2.25480.037617.082361.1927AID1259364; AID1259388
nuclear factor erythroid 2-related factor 2 isoform 1Homo sapiens (human)Potency54.26110.000627.21521,122.0200AID743202; AID743219
Voltage-dependent calcium channel gamma-2 subunitMus musculus (house mouse)Potency19.25260.001557.789015,848.9004AID1259244
Glutamate receptor 2Rattus norvegicus (Norway rat)Potency19.25260.001551.739315,848.9004AID1259244
ATPase family AAA domain-containing protein 5Homo sapiens (human)Potency14.30280.011917.942071.5630AID651632; AID720516
Ataxin-2Homo sapiens (human)Potency8.59980.011912.222168.7989AID651632
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Neutrophil elastaseHomo sapiens (human)IC50 (µMol)39.00000.00632.073422.3780AID66480
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (43)

Processvia Protein(s)Taxonomy
proteolysisNeutrophil elastaseHomo sapiens (human)
negative regulation of transcription by RNA polymerase IINeutrophil elastaseHomo sapiens (human)
response to yeastNeutrophil elastaseHomo sapiens (human)
leukocyte migration involved in inflammatory responseNeutrophil elastaseHomo sapiens (human)
biosynthetic process of antibacterial peptides active against Gram-negative bacteriaNeutrophil elastaseHomo sapiens (human)
proteolysisNeutrophil elastaseHomo sapiens (human)
intracellular calcium ion homeostasisNeutrophil elastaseHomo sapiens (human)
response to UVNeutrophil elastaseHomo sapiens (human)
extracellular matrix disassemblyNeutrophil elastaseHomo sapiens (human)
protein catabolic processNeutrophil elastaseHomo sapiens (human)
response to lipopolysaccharideNeutrophil elastaseHomo sapiens (human)
negative regulation of chemokine productionNeutrophil elastaseHomo sapiens (human)
negative regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
positive regulation of interleukin-8 productionNeutrophil elastaseHomo sapiens (human)
defense response to bacteriumNeutrophil elastaseHomo sapiens (human)
positive regulation of MAP kinase activityNeutrophil elastaseHomo sapiens (human)
positive regulation of smooth muscle cell proliferationNeutrophil elastaseHomo sapiens (human)
negative regulation of inflammatory responseNeutrophil elastaseHomo sapiens (human)
positive regulation of immune responseNeutrophil elastaseHomo sapiens (human)
negative regulation of chemotaxisNeutrophil elastaseHomo sapiens (human)
pyroptosisNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of gram-negative bacteriumNeutrophil elastaseHomo sapiens (human)
neutrophil-mediated killing of fungusNeutrophil elastaseHomo sapiens (human)
positive regulation of leukocyte tethering or rollingNeutrophil elastaseHomo sapiens (human)
phagocytosisNeutrophil elastaseHomo sapiens (human)
acute inflammatory response to antigenic stimulusNeutrophil elastaseHomo sapiens (human)
cell population proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of B cell proliferationATPase family AAA domain-containing protein 5Homo sapiens (human)
nuclear DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
signal transduction in response to DNA damageATPase family AAA domain-containing protein 5Homo sapiens (human)
intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
isotype switchingATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of DNA replicationATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of isotype switching to IgG isotypesATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloadingATPase family AAA domain-containing protein 5Homo sapiens (human)
regulation of mitotic cell cycle phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediatorATPase family AAA domain-containing protein 5Homo sapiens (human)
positive regulation of cell cycle G2/M phase transitionATPase family AAA domain-containing protein 5Homo sapiens (human)
negative regulation of receptor internalizationAtaxin-2Homo sapiens (human)
regulation of translationAtaxin-2Homo sapiens (human)
RNA metabolic processAtaxin-2Homo sapiens (human)
P-body assemblyAtaxin-2Homo sapiens (human)
stress granule assemblyAtaxin-2Homo sapiens (human)
RNA transportAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (15)

Processvia Protein(s)Taxonomy
protease bindingNeutrophil elastaseHomo sapiens (human)
transcription corepressor activityNeutrophil elastaseHomo sapiens (human)
endopeptidase activityNeutrophil elastaseHomo sapiens (human)
serine-type endopeptidase activityNeutrophil elastaseHomo sapiens (human)
protein bindingNeutrophil elastaseHomo sapiens (human)
heparin bindingNeutrophil elastaseHomo sapiens (human)
peptidase activityNeutrophil elastaseHomo sapiens (human)
cytokine bindingNeutrophil elastaseHomo sapiens (human)
protein bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
ATP hydrolysis activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA clamp unloader activityATPase family AAA domain-containing protein 5Homo sapiens (human)
DNA bindingATPase family AAA domain-containing protein 5Homo sapiens (human)
RNA bindingAtaxin-2Homo sapiens (human)
epidermal growth factor receptor bindingAtaxin-2Homo sapiens (human)
protein bindingAtaxin-2Homo sapiens (human)
mRNA bindingAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (21)

Processvia Protein(s)Taxonomy
extracellular regionNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
cytoplasmNeutrophil elastaseHomo sapiens (human)
cytosolNeutrophil elastaseHomo sapiens (human)
cell surfaceNeutrophil elastaseHomo sapiens (human)
secretory granuleNeutrophil elastaseHomo sapiens (human)
azurophil granule lumenNeutrophil elastaseHomo sapiens (human)
specific granule lumenNeutrophil elastaseHomo sapiens (human)
phagocytic vesicleNeutrophil elastaseHomo sapiens (human)
collagen-containing extracellular matrixNeutrophil elastaseHomo sapiens (human)
extracellular exosomeNeutrophil elastaseHomo sapiens (human)
transcription repressor complexNeutrophil elastaseHomo sapiens (human)
extracellular spaceNeutrophil elastaseHomo sapiens (human)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
Elg1 RFC-like complexATPase family AAA domain-containing protein 5Homo sapiens (human)
nucleusATPase family AAA domain-containing protein 5Homo sapiens (human)
cytoplasmAtaxin-2Homo sapiens (human)
Golgi apparatusAtaxin-2Homo sapiens (human)
trans-Golgi networkAtaxin-2Homo sapiens (human)
cytosolAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
membraneAtaxin-2Homo sapiens (human)
perinuclear region of cytoplasmAtaxin-2Homo sapiens (human)
ribonucleoprotein complexAtaxin-2Homo sapiens (human)
cytoplasmic stress granuleAtaxin-2Homo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (25)

Assay IDTitleYearJournalArticle
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID361174Cytotoxicity against human SW1573 cells after 3 days by MTT assay2001Journal of natural products, Jun, Volume: 64, Issue:6
Chemical constituents from Lippia sidoides and cytotoxic activity.
AID1332112Effect on total AMPK expression in mouse C2C12 cells at 10 uM after 2 hrs by Western blot analysis2017Bioorganic & medicinal chemistry letters, 01-01, Volume: 27, Issue:1
Anthraquinones from Morinda longissima and their insulin mimetic activities via AMP-activated protein kinase (AMPK) activation.
AID1332113Induction of AMPK alpha phosphorylation at Thr172 residue in mouse C2C12 cells at 10 uM pretreated with AMPK inhibitor compound C for 10 mins followed by compound addition measured after 2 hrs by Western blot analysis2017Bioorganic & medicinal chemistry letters, 01-01, Volume: 27, Issue:1
Anthraquinones from Morinda longissima and their insulin mimetic activities via AMP-activated protein kinase (AMPK) activation.
AID361175Cytotoxicity against human CEM cells after 3 days by MTT assay2001Journal of natural products, Jun, Volume: 64, Issue:6
Chemical constituents from Lippia sidoides and cytotoxic activity.
AID1293750Antiproliferative activity against human MCF7 cells assessed as growth inhibition after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, May-01, Volume: 26, Issue:9
Two novel phenanthraquinones with anti-cancer activity isolated from Bletilla striata.
AID361173Cytotoxicity against human HL60 cells after 3 days by MTT assay2001Journal of natural products, Jun, Volume: 64, Issue:6
Chemical constituents from Lippia sidoides and cytotoxic activity.
AID48201Compound was tested for the enzyme inhibitory activity against Cathepsin G (CatG); NI = no inhibition1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID67634Compound is measured for surviving fractions of EMT6 tumor cells treated in culture with (0.50 uM) concentration for 1 hr under aerobic condition.1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
2-Methylanthraquinone derivatives as potential bioreductive alkylating agents.
AID67635Compound is measured for surviving fractions of EMT6 tumor cells treated in culture with (0.50 uM) concentration for 1 hr under hypoxic condition.1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
2-Methylanthraquinone derivatives as potential bioreductive alkylating agents.
AID660831Cytotoxicity against human ACHN cells assessed as cell death after 20 to 24 hrs by XTT assay2012Journal of natural products, Mar-23, Volume: 75, Issue:3
Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima.
AID500083Antifungal activity against Candida albicans ATCC 777 by broth microdilution method2010Journal of natural products, Aug-27, Volume: 73, Issue:8
Lactones and quinones from the tubers of Sinningia aggregata.
AID1332110Activation of AMPK in mouse 3T3L1 adipocytes assessed as increase in 2-NBDG uptake at 10 uM after 90 mins by fluorescence microscopy2017Bioorganic & medicinal chemistry letters, 01-01, Volume: 27, Issue:1
Anthraquinones from Morinda longissima and their insulin mimetic activities via AMP-activated protein kinase (AMPK) activation.
AID1332111Induction of AMPK alpha phosphorylation at Thr172 residue in mouse C2C12 cells at 10 uM after 2 hrs by Western blot analysis2017Bioorganic & medicinal chemistry letters, 01-01, Volume: 27, Issue:1
Anthraquinones from Morinda longissima and their insulin mimetic activities via AMP-activated protein kinase (AMPK) activation.
AID1293753Antiproliferative activity against human A549 cells assessed as growth inhibition after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, May-01, Volume: 26, Issue:9
Two novel phenanthraquinones with anti-cancer activity isolated from Bletilla striata.
AID1332109Activation of AMPK in mouse 3T3L1 adipocytes assessed as increase in 2-NBDG uptake at 10 uM after 90 mins by fluorescence assay2017Bioorganic & medicinal chemistry letters, 01-01, Volume: 27, Issue:1
Anthraquinones from Morinda longissima and their insulin mimetic activities via AMP-activated protein kinase (AMPK) activation.
AID500084Antifungal activity against Candida albicans ATCC 778157 by broth microdilution method2010Journal of natural products, Aug-27, Volume: 73, Issue:8
Lactones and quinones from the tubers of Sinningia aggregata.
AID343962Inhibition of 12-O-tetradecanoylphorbol-13-acetate induced EBV-early antigen activation in human Raji cells2008Bioorganic & medicinal chemistry letters, Jul-15, Volume: 18, Issue:14
Correlation between reduction potentials and inhibitions of Epstein-Barr virus activation by anthraquinone derivatives.
AID1293752Antiproliferative activity against human HUVEC cells assessed as growth inhibition after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, May-01, Volume: 26, Issue:9
Two novel phenanthraquinones with anti-cancer activity isolated from Bletilla striata.
AID1293751Antiproliferative activity against human HT-29 cells assessed as growth inhibition after 48 hrs by MTT assay2016Bioorganic & medicinal chemistry letters, May-01, Volume: 26, Issue:9
Two novel phenanthraquinones with anti-cancer activity isolated from Bletilla striata.
AID66480In vitro inhibition of human leukocyte elastase.1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID231332Ratio of toxicity in areobic conditions to hypoxic condition of EMT6 cells1980Journal of medicinal chemistry, Nov, Volume: 23, Issue:11
2-Methylanthraquinone derivatives as potential bioreductive alkylating agents.
AID660832Cytotoxicity against human ACHN cells assessed as cell death after 20 to 24 hrs by XTT assay in presence of 40 ng/ml TRAIL2012Journal of natural products, Mar-23, Volume: 75, Issue:3
Synergistic TRAIL sensitizers from Barleria alluaudii and Diospyros maritima.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (23)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (13.04)18.7374
1990's2 (8.70)18.2507
2000's4 (17.39)29.6817
2010's12 (52.17)24.3611
2020's2 (8.70)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 30.36

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index30.36 (24.57)
Research Supply Index3.18 (2.92)
Research Growth Index4.97 (4.65)
Search Engine Demand Index29.56 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (30.36)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other23 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]